baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

BVT Knock-Out PGR/ DE000VM6DUE9 /

14/06/2024 21:37:49	Chg.+0.12	Bid22:00:03	Ask22:00:03	Underlying	Strike price	Expiration date	Option type
6.19EUR	+1.98%	- Bid Size: -	- Ask Size: -	Progressive Corporat...	139.20 USD	31/12/2078	Call

GlobeNewswire 14/06 Progressive Reports May 2024 Results

GlobeNewswire 13/06 Dyne Therapeutics Presents New Preclinical Data for its Facioscapulohumeral Muscular Dystrophy Progr...

GlobeNewswire 12/06 Ultragenyx Announces Plans to File for Accelerated Approval of UX111 for the Treatment of Sanfilippo...

GlobeNewswire 12/06 Belite Bio Receives Sakigake (Pioneer Drug) Designation of Tinlarebant for Stargardt Disease in Japa...

GlobeNewswire 11/06 Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D ...

GlobeNewswire 11/06 Processa Pharmaceuticals Announces Positive Efficacy Results from Preliminary Evaluation of Phase 1b...

GlobeNewswire 11/06 FDA Accepts Tiziana Life Sciences Fast Track Designation Submission for Treatment of Multiple Sclero...

GlobeNewswire 10/06 LifeWallet’s Proprietary Data System is Instrumental in Class Certification Against USAA Property an...

GlobeNewswire 10/06 SYFOVRE® (pegcetacoplan injection) Preserved Visual Function at 36 Months in GALE Extension Study in...

TeleTrader 09/06 EP updated results, EPP with 189 seats

TeleTrader 09/06 EPP's Weber claims party victory in EP election

GlobeNewswire 07/06 TG Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

GlobeNewswire 07/06 Boehringer Ingelheim’s survodutide shows breakthrough improvement in liver fibrosis with no worsenin...

GlobeNewswire 06/06 Tiziana Life Sciences Announces Six-Month Qualitative Improvement in Neuroimaging in 80% of Multiple...

GlobeNewswire 06/06 4DMT Presents Positive Interim Data from Phase 1/2 AEROW Clinical Trial of Aerosolized 4D-710 for Mo...

GlobeNewswire 05/06 The Alignment Studio Physiotherapy Melbourne Celebrates Receiving Only 5-Star Reviews Since Opening

GlobeNewswire 05/06 MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Preventio...

GlobeNewswire 05/06 Ipsen presents long-term elafibranor efficacy and itch-related quality of life data in patients with...

GlobeNewswire 04/06 Tiziana Life Sciences Submits Grant Application to ALS Association to Fund Clinical Trial of Intrana...

GlobeNewswire 04/06 Amicus Therapeutics Receives Prix Galien U.K. Award for Pombiliti® (cipaglucosidase alfa) + Opfolda®...

GlobeNewswire 03/06 Opthea To Present at Clinical Trials at the Summit Meeting

GlobeNewswire 03/06 TG Therapeutics to Participate in the Jefferies Global Healthcare Conference

GlobeNewswire 03/06 MediciNova Announces Data from Phase 1b/2a Clinical Trial of MN-166 (ibudilast) in Glioblastoma Pati...

GlobeNewswire 31/05 TG Therapeutics Announces Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the 2024...

GlobeNewswire 30/05 Biogen Receives European Commission Approval for QALSODY® (tofersen), the First Therapy to Treat a R...

BVT Knock-Out PGR/ DE000VM6DUE9 /

If you wish to receive reply to your feedback, please provide your email address.